Paclitaxel disrupts polarized entry of membrane-permeable C6 ceramide into ovarian cancer cells resulting in synchronous induction of cell death

Oncology Letters

Volumn 5, Issue 6, 2013, Pages 1854-1858

  Best, Charles ^a   Calianese, David ^a   Szulak, Kevin ^a   Cammarata, Garret ^a   Brum, Gabriella ^a   Carbone, Thomas ^a   Still, Eric ^a   Higgins, Katelyn ^a   Ji, Fang ^a   Di, Wen ^b   Wanebo, Harold ^c   Wan, Yinsheng ^a  

^a PROVIDENCE COLLEGE   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Landmark Medical Center   (United States)

Author keywords

AKT; C6 ceramide; Ovarian cancer; Paclitaxel

Indexed keywords

AQUAPORIN; C6 CERAMIDE; CERAMIDE; DOXORUBICIN; PACLITAXEL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER MORTALITY; CAVEOLA; CELL CULTURE; CONFOCAL MICROSCOPY; DRUG POTENTIATION; HUMAN; HUMAN CELL; OVARY CANCER;

EID: 84876494388     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1305     Document Type: Article

References (25)

1. Bourteele S, Hausser A, Döppler H, Horn-Müller J, Röpke C, Schwarzmann G, Pfzenmaier K and Müller G: Tumor necrosis factor induces ceramide oscillations and negatively controls sphingolipid synthases by caspases in apoptotic Kym-1 cells. J Biol Chem 273: 31245-31251, 1998.
2. Zhan D, Santin AD, Liu Y, Parham GP, Li C, Meyers C and Hermonat PL: Binding of the human papillomavirus type 16 p97 promoter by the adeno-associated virus Rep78 major regulatory protein correlates with inhibition. J Biol Chem 274: 31619-31624, 1999.
3. Chapman J V, Gouazé-Andersson V, Messner MC, Flowers M, Karimi R, Kester M, Barth BM, Liu X, Liu YY, Giuliano AE and Cabot MC: Metabolism of short-chain ceramide by human cancer cells - implications for therapeutic approaches. Biochem Pharmacol 80: 308-315, 2010.
4. Lavie Y, Cao HT, Volner A, Lucci A, Han TY, Geffen V, Giuliano AE and Cabot MC: Agents that reverse multidrug resistance, tamoxifen, verapamil and cyclosporin A, block glyco-sphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J Biol Chem 272: 1682-1687, 1997.
5. Chang MS, Sasaki H, Campbell MS, Kraeft SK, Sutherland R, Yang CY, Liu Y, Auclair D, Hao L, Sonoda H, Ferland LH and Chen LB: HRad17 colocalizes with NHP2L1 in the nucleolus and redistributes after UV irradiation. J Biol Chem 274: 36544-36549, 1999.
6. Lucci A, Giuliano AE, Han TY, Dinur T, Liu YY, Senchenkov A and Cabot MC: Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells. Int J Oncol 15: 535-540, 1999.
7. Giussani P, Bassi R, Anelli V, Brioschi L, De Zen F, Riccitelli E, Caroli M, Campanella R, Gaini SM, Viani P and Riboni L: Glucosylceramide synthase protects glioblastoma cells against autophagic and apoptotic death induced by temozolomide and Paclitaxel. Cancer Invest 30: 27-37, 2012.
8. Lucci A, Han TY, Liu YY, Giuliano AE and Cabot MC: Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics. Int J Oncol 15: 541-546, 1999.
9. Carlier MF and Pantaloni D: Taxol effect on tubulin polymerization and associated guanosine 5'-triphosphate hydrolysis. Biochemistry 22: 4814-4822, 1983.
10. Myrick D, Blackinton D, Klostergaard J, Kouttab N, Maizel A, Wanebo H and Mehta S: Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide. Leuk Res 23: 569-578, 1999.
11. Gatei M, Young D, Cerosaletti KM, Desai-Mehta A, Spring K, Kozlov S, Lavin MF, Gatti RA, Concannon P and Khanna K: ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nat Genet 25: 115-119, 2000.
12. Charles AG, Han TY, Liu YY, Hansen N, Giuliano AE and Cabot MC: Taxol-induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemother Pharmacol 47: 444-450, 2001.
13. Liu Y, Qiu L and Li C: Effect of radiation on nasal mucosa and the microvascular casting of guinea pig. Lin Chuang Er Bi Yan Hou Ke Za Zhi 20: 793-796, 2006 (In Chinese).
14. Devalapally H, Duan Z, Seiden MV and Amiji MM: Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer. Int J Cancer 121: 1830-1838, 2007.
15. Kolesnick R, Altieri D and Fuks Z: A CERTain role for ceramide in taxane-induced cell death. Cancer Cell 11: 473-475, 2007.
16. Swanton C, Marani M, Pardo O, Warne PH, Kelly G, Sahai E, Elustondo F, Chang J, Temple J, Ahmed AA, Brenton JD, Downward J and Nicke B: Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell 11: 498-512, 2007.
17. Lee AJ, Roylance R, Sander J, Gorman P, Endesfelder D, Kschischo M, Jones NP, East P, Nicke B, Spassieva S, Obeid LM, Birkbak NJ, Szallasi Z, McKnight NC, Rowan AJ, Speirs V, Hanby AM, Downward J, Tooze SA and Swanton C: CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy induction. J Pathol 226: 482-494, 2012.
18. Qiu L, Zhou C, Sun Y, Di W, Scheffer E, Healey S, Wanebo H, Kouttab N, Chu W and Wan Y: Paclitaxel and ceramide synergis-tically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells. Oncol Rep 16: 907-913, 2006.
19. Kuebler WM, Yang Y, Samapati R and Uhlig S: Vascular barrier regulation by PAF, ceramide, caveolae and NO - an intricate signaling network with discrepant effects in the pulmonary and systemic vasculature. Cell Physiol Biochem 26: 29-40, 2010.
20. Hara-Chikuma M, Chikuma S, Sugiyama Y, Kabashima K, Verkman AS, Inoue S and Miyachi Y: Chemokine-dependent T cell migration requires aquaporin-3-mediated hydrogen peroxide uptake. J Exp Med 209: 1743-1752, 2012.
21. Virreira M, Perret J and Delporte C: Pancreatic beta-cells: Role of glycerol and aquaglyceroporin 7. Int J Biochem Cell Biol 43: 10-13, 2011.
22. Zheng X and Bollinger Bollag W: Aquaporin 3 colocates with phospholipase d2 in caveolin-rich membrane microdomains and is downregulated upon keratinocyte differentiation. J Invest Dermatol 121: 1487-1495, 2003.
23. Cao C, Sun Y, Healey S, Bi Z, Hu G, Wan S, Kouttab N, Chu W and Wan Y: EGFR-mediated expression of aquaporin-3 is involved in human skin fbroblast migration. Biochem J 400: 225-234, 2006.
24. Ji C, Cao C, Lu S, Kivlin R, Amaral A, Kouttab N, Yang H, Chu W, Bi Z, Di W and Wan Y: Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells. Cancer Chemother Pharmacol 62: 857-865, 2008.
25. Kelland LR: Emerging drugs for ovarian cancer. Expert Opin Emerg Drugs 10: 413-424, 2005.